Ashkan Michael Abbey MD

Retinal Disease

Medical and Surgical Vitreoretinal Specialist

9600 N Central ExpySte 100Dallas, TX 75231
Phone+1 214-692-6941
Fax+1 214-692-0139

Dr. Abbey is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Abbey's full profile Already have an account?

Summary

Dr. Ashkan Abbey is an ophthalmologist based in Dallas, TX, specializing in retinal diseases. He has an extensive educational background, including a magna cum laude A.B. in Biological Sciences with a Language Citation in Spanish from Harvard University, followed by a medical degree from Weill Cornell Medicine. He completed a residency in ophthalmology at the University of Miami/Jackson Health System/Bascom Palmer Eye Institute and pursued fellowship training in surgical retina and vitreous at Beaumont Health and the Associated Retinal Consultants/William Beaumont Hospital. His expertise encompasses diabetic retinopathy, vitreous detachment, and macular degeneration, with contributions to research in these areas resulting in several publications. Dr. Abbey has received numerous honors, including the Retina Fellows’ Forum Research Award and the Edward Norton Prize in Ophthalmology. He participated in a clinical trial evaluating the safety of Ozurdex with Eylea.

Education & Training

Beaumont HealthFellowship, Surgical Retina and Vitreous, 2013 - 2015
Associated Retinal Consultants / William Beaumont Hospital (Royal Oak)Fellowship, Surgical Retina and Vitreous, 2013 - 2015
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2010 - 2013
Scripps Mercy HospitalInternship, Transitional Year, 2009 - 2010
Weill Cornell MedicineClass of 2009

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

TX State Medical License 2015 - 2027
MI State Medical License 2013 - 2017
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification IntelleChart, MDIntelleSys, A Nextech Company, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014, 2016-2017
Alpha Omega Alpha Honor Society 2008

Clinical Trials

One Year Trial Evaluating Safety of Ozurdex With Eylea Start of enrollment: 2019 Jun 11
COMPLETED
PHASE4

Publications & Presentations

PubMed

DEXAMETHASONE IMPLANT AND AFLIBERCEPT COMBINATION THERAPY VERSUS AFLIBERCEPT MONOTHERAPY FOR DIABETIC MACULAR EDEMA: A Prospective, Comparative Trial (COED Trial).
Irene Park Kim, Christine Orndahl, Caroline Nyaiburi, Rajiv Anand, David Callanan
Retina. 2026-09-01
Home OCT Monitoring as a Safety Net for Early Detection of Recurrent Disease Activity in Neovascular Age-Related Macular Degeneration Under Standard Care.
Deepak Sambhara, Ashkan M Abbey, David A Eichenbaum
Medicina. 2026-06-26
INJECTABLE INTRAVITREAL FLUOCINOLONE ACETONIDE IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA IN THE PRESENCE OF SILICONE OIL TAMPONADE.
Kishan G Patel, Jessica Flores, Ashkan M Abbey
Retinal Cases & Brief Reports. 2026-01-01

Journal Articles

Macular cavernous hemangioma associated with peripheral vascular anomalies and nonperfusion
Rao P, Abbey AM, Yonekawa Y, Shah AR, Capone A Jr., Trese MT, Drenser KA, Ophthalmic Surg Lasers Imaging Retina, 1/1/2015
Association of Autosomal Dominant Familial Exudative Vitreoretinopathy and Spinal Muscular Atrophy
Mammo D, Yonekawa Y, Thomas BJ, Shah AR, Abbey AM, Trese MT, Drenser KA, Capone A, European Journal of Ophthalmology, 1/1/2015
Association Between Subfoveal Choroidal Thickness, Reticular Pseudodrusen, and Geographic Atrophy in Age-Related Macular Degeneration
Thorell MR, Goldhardt R, Nunes RP, Garcia Filho CA, Abbey AM, Kuriyan AE, Modi YS, Gregori G, Yehoshua Z, Feuer W, Sadda SR, Rosenfeld PJ, Ophthalmic Surg Lasers Imaging Retina, 1/1/2015

Books/Book Chapters

Corneal Topography: A Guide for Clinical Application in the Wavefront Era
Chapter: Corneal Anatomy and Optics
Page 11 - 19Abbey AM, Yoo SHEditors: Ming Wang, MD, PhD.SLACK, IncEdition 2nd,2012
Keratoconus & Keratoectasia: Prevention, Diagnosis, and Treatment
Chapter: Anatomy, Physiology, and Molecular Biology
Page 3 - 10Abbey AM,Yoo SHEditors: Ming Wang, MD, PhD.SLACK, Inc2010

Abstracts/Posters

Peripheral Retinal Vascular Findings in Adults and Children
Trese MT, Shah AR, Abbey AM, Angiogenesis, Exudation, and Degeneration, Miami, FL, 1/7/2015
Choroidal Neovascular Membranes in Pediatric Subjects: Clinical Characteristics and Outcomes
Padhi TR, Abbey AM, Anderson BJ, Alam D, Modi R, Drenser KA, Capone A Jr, Trese MT, Besirli CG, Association for Research in Vision and Ophthalmology Annual Meeting, Denver, CO, 1/4/2015
Psychiatric Ophthalmology
Abbey AM, Williams GA, Mayo Clinic Retina Update and Case Conference, Rochester, MN, 10/31/2014

Lectures

Telemedicine Diagnosis of Plus Disease in Retinopathy of Prematurity: Accuracy of Expert versus Computer-assisted Quantitative Vascular Analysis
Vienna, Austria - 1/13/2015

Other

Sutureless Transconjunctival Cannula-Based Fixation
Abbey AM, Wolfe JD, The American Academy of Ophthalmology Website: Clinical Education
http://www.aao.org
1/19/2015
IOL Exchange with Sutureless Transconjunctival Cannula-Based Scleral Fixation
Abbey AM, Wolfe JD, Williams GA, The American Society of Retina Specialists Website: Innovative Retina Surgical Video Series
http://www.asrs.org
1/12/2015
27-Gauge Sutureless Transconjunctival Cannula-Based Scleral Fixation of Dislocated 3-Piece IOL
Abbey AM, Wolfe JD, Williams GA, The American Society of Retina Specialists Website: Innovative Retina Surgical Video Series
http://www.asrs.org
1/12/2015

Press Mentions

Eluminex Biosciences Announces Phase 1b Single Ascending Dose Study Results of a Novel Pentavalent Trispecific Fusion Antibody (EB-105) in Patients with Diabetic Macular Edema (DME)June 9th, 2025
Dealing with Post-Cataract InflammationMarch 21st, 2025
Eluminex Biosciences Announces FDA Acceptance of Investigational New Drug (IND) Application for EB-105 - a Novel Trispecific Fusion Antibody for Diabetic Macular Edema (DME) - and Upcoming Scientific PresentationsJuly 16th, 2024